Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-27T14:33:56.773Z Has data issue: false hasContentIssue false

Evolution of the management of depression in Spain from the psychiatrist’s perspective. A comparative analysis: 1997 vs 1982

Published online by Cambridge University Press:  16 April 2020

J.J. López-Ibor
Affiliation:
Department of Psychiatry, Complutense University, Madrid, Spain
C. Alamo
Affiliation:
Neuropsychopharmacology Unit, Department of Pharmacology, University of Alcalá, Madrid, Spain
F. López-Muñoz
Affiliation:
Neuropsychopharmacology Unit, Department of Pharmacology, University of Alcalá, Madrid, Spain
E. Cuenca
Affiliation:
Neuropsychopharmacology Unit, Department of Pharmacology, University of Alcalá, Madrid, Spain
G. Rubio
Affiliation:
Department of Psychiatry, Autónoma University, Madrid, Spain
F.J. Otero*
Affiliation:
Mental Health Services, Collado-Villalba, Madrid, Spain
*
*Correspondence and reprints: Professor Cecilio Alamo, C/ Julio Camba, 7. 28028 Madrid, Spain
Get access

Summary

The main problem of depression is not only the high prevalence of the disorder but also its serious consequences on the patient’s quality of life and the associated social costs in terms of health care resource utilization and productivity losses. In recent years, there has been a considerable improvement in the knowledge of depression from the pathogenic, clinical and therapeutic perspectives. The present study analyzes whether such advances are reflected in a positive evolution of the treatment of depression in Spain. To this effect we have contrasted the results of two socio-sanitary studies published in this country: the White Book editions of 1982 and 1997 (WB82 and WB97, respectively). From the methodological perspective, the physician selection criteria employed were very uniform (structured questionnaires delivered to 128 (WB82) and 300 (WB97) randomly selected psychiatrists). The origin of patients consulting for specialized care has varied over this 15-year period. In effect, WB82 patients were essentially referred by friends (87.5%) and from the primary care setting (44.5%), whereas in the WB97 study referral from primary care predominated (50.1%), followed by the patient’s personal decision (24.8%). In turn, 40.7% and 51.7% of the psychiatrists in WB97 respectively considered the diagnostic and therapeutic means available in primary care to be insufficient. The priorities for improving patient quality of life, as reflected by both editions of the study, were the training of primary care physicians and the adequate provision of means in the mental health care centers. On the other hand, fewer problems for establishing a correct diagnosis were referred in the 1997 edition of the study (28.7%) than in 1982 (48.4%). In this sense, the main problem reported in WB82 was the lack of specialized training, whereas the masking of depression by some other disease process or symptoms was the main problem in WB97 (67.6% vs 21.1% according to WB82). The main symptoms upon which the diagnosis of depression are based do not seem to have evolved much in the past 15 years. The most frequently cited manifestations were a worsening of mood, loss of interest and leisure capacity, sleep alterations and diminished vitality. A comparative analysis of the therapeutic resources used was not possible, for prior to 1982 the only drugs available to physicians were the classical tricyclic agents and some MAO inhibitors; the selective serotonin reuptake inhibitors (SSRIs) – possibly the greatest advance in the treatment of depression in these 15 years – had not yet been introduced. Nevertheless, it should be pointed out that 98% of the psychiatrists consulted in WB97 considered pharmacologic treatment to be the most widely adopted form of management once depression has been diagnosed.

Type
Original article
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alamo, C, López-Muñoz, F, Cuenca, EGli SSRI nella pratica clinica e la loro validità rispetto agli antidepressivi triciclici Psichiatr M 2 1997 2Google Scholar
Alonso, M.P, De Abajo, F.J, Martínez, J.J, Montero, D, Martín-Serrano, G, Madurga, MEvolución del consumo de antidepresivos en España. Impacto de los inhibidores selectivos de la recaptación de serotonina Med Clin (Barc) 108 1997 161–166Google Scholar
Blazer, D.G, Kessler, R.C, McGonagle, K.A, Swartz, M.SThe prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey Am J Psychiatry 151 1994 979–986Google Scholar
Borrás Martínez, P, Fibla Nolla, M, Villó Vallés, CPrevalencia de morbilidad psíquica en una consulta de atención primaria Salud Rural 3 1997 80–86Google Scholar
Craig, T.J, Van Natta, P.APresence and persistence of depressive symptoms in patient and community populations Am J Psychiatry 133 1976Google ScholarPubMed
Gabinete de estudios sociológicos Bernard Krief Estudio sociológico Libro Blanco “La depresión en España” 1982 Madrid: publisherGoogle Scholar
Gabinete de estudios sociológicos Bernard Krief Estudio sociosanitario Libro Blanco “La calidad asistencial de la depresión en España” 1997 Madrid: publisherGoogle Scholar
Girolamo, GDiferencias transculturales en la depresión Focus Depress 3 1993 28–40Google Scholar
Henry, J.A, Alexander, C.A, Sener, E.KRelative mortality from overdose of antidepressants Br Med J 310 1995 221–224CrossRefGoogle ScholarPubMed
Henry, J.A, Rivas, C.AConstraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment Pharmacoeconomics 11 1997 419–443CrossRefGoogle ScholarPubMed
Katon, W, Von Korff, M, Lin, E, Walker, E, Simon, G.E, Bush, T et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care JAMA 273 1995 1026–1031CrossRefGoogle ScholarPubMed
Lepine, J.P, Gastpar, M, Mendlewicz, J, Tylee, ADepression in the community: the first pan-European study DEPRES (Depression Research in European Society) Int Clin Psychopharmacol 12 1997 19–29CrossRefGoogle Scholar
López-Ibor, J.JMasked depression under the light of new biological and nosological research Encephale 18 Suppl 1 1992 35–39Google ScholarPubMed
López-Ibor, J.J, Alamo, C, López-Muñoz, F, Cuenca, E, Rubio, G, Otero, F.JA comparative analysis of depression management in primary care practice in Spain: 1997 versus 1982 Prim Care Psychiatry 5 1999 133–145Google Scholar
López-Muñoz, F, Alamo, C, Cuenca, E, Rubio, GEfecto de los fármacos antidepresivos sobre los isoenzimas del citocromo P-450 y su trascendencia clínica: perfil diferencial Actas Luso Esp Neurol Psiquiatr 25 1997 397–409Google Scholar
Mannheimer, D.IPatterns of drugs acquisition and useBerkeley (CA) 1974 Institute for Research in Social BehaviorGoogle Scholar
Muller, H.J, Volz, H.PDrug treatment of depression in the 1990s: an overview of achievements and future possibilities Drugs 52 1996 625–63810.2165/00003495-199652050-00001CrossRefGoogle Scholar
Ofisalud and Gabinete de estudios sociológicosKrief, BernardEstudio socioeconómico Libro Blanco “El coste social de los trastornos de salud mental en España” 1998 Madrid: publisherGoogle Scholar
Sartorius, N, Ustun, T.B, Costa, J.A, Goldberg, D, Lecrubier, Y, Ormel, J et al. An international study of psychological problems in primary care: preliminary report from the World Health Organization. Collaborative project on “psychological problems in general health care” Arch Gen Psychiatry 50 1993 819–824CrossRefGoogle Scholar
Simon, G.E, Von Korff, M, Barlow, WHealth care costs of primary care patients with recognized depression Arch Gen Psychiatry 52 1995 850–856CrossRefGoogle ScholarPubMed
Vázquez-Barquero, J, Díez-Manrique, J, Peña, C, Aldama, J, Samaniego-Rodríguez, C, Menéndez-Arango, J et al. A community mental health survey in Cantabria: a general description of morbidity Psychol M 17 1987 227–241CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.